LiDORx® contains 3% lidocaine in a patented transdermal delivery system. Provides topical non-narcotic temporary relief for pain as prescribed by a physician.
• Accurate dosing - metered dose technology (MDose™) dispenses the exact amount of medication
• Patient friendly
• Onset of action as fast as five minutes from time of application
LiDORx® is an amide type local anesthetic indicated for: anesthetic for use before minor medical procedures, i.e., injections; Relief of pain, soreness, abrasions, minor burns, insect bites and discomfort due to pruritus, pruritic eczemas, pruritus ani, pruritus vulvae, hemorrhoids, anal fissures, and similar conditions of the skin and mucous membranes.
Traumatized mucosa, secondary bacterial infection of the area of proposed application and known hypersensitivity to any of the components. Lidocaine hydrochloride USP is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type.
For external use only. Avoid contact with eyes. If irritation or sensitivity occurs or infection appears, discontinue use and institute appropriate therapy. LiDORx® should be used with caution in ill, elderly, debilitated patients and children who may be more sensitive to the systemic effects of lidocaine hydrochloride USP.
Most common adverse reactions are redness or swelling at the application site. Less common side effects, such as sluggishness, confusion, slow breathing, low blood pressure, or slow heartbeat, may occur.
Store at 25ºC (77ºF); excursions permitted to 15º-30ºC (59º-86º F). See USP Controlled Room Temperature. Protect from freezing.
Lidocaine hydrochloride 3%
Aqua (deionized water), carbomer, isopropyl alcohol, petrolatum, polysorbate-20, triethanolamine
|Variety of sizes||●|
|Educational Material Available||●|
|Free Samples/Trials Available|
|Published Clinical Article Available||●|
Apply 1-4 pumps QID over 24 hours. Maximum 16 pumps in 24 hours.
Gensco Pharma is a specialty pharmaceutical company focusing on research, development and marketing of transdermal prescription products.